Annual ROE:
-219.59%-525.07%(-171.88%)Summary
- As of today, CDTX annual return on equity is -219.59%, with the most recent change of -525.07% (-171.88%) on December 31, 2024.
- During the last 3 years, CDTX annual ROE has risen by +43.46% (+16.52%).
- CDTX annual ROE is now -171.88% below its all-time high of 305.48%, reached on December 31, 2023.
Performance
CDTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly ROE:
-55.62%+118.23%(+68.01%)Summary
- As of today, CDTX quarterly return on equity is -55.62%, with the most recent change of +118.23% (+68.01%) on June 30, 2025.
- Over the past year, CDTX quarterly ROE has increased by +389.83% (+87.51%).
- CDTX quarterly ROE is now -74.63% below its all-time high of -31.85%, reached on June 30, 2015.
Performance
CDTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CDTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -171.9% | +87.5% |
| 3Y3 Years | +16.5% | +94.4% |
| 5Y5 Years | -159.1% | +49.5% |
CDTX ROE Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -171.9% | +76.7% | at high | +95.6% |
| 5Y | 5-Year | -171.9% | +76.7% | at high | +95.6% |
| All-Time | All-Time | -171.9% | +76.7% | -74.6% | +95.6% |
CDTX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -55.62%(+68.0%) |
| Mar 2025 | - | -173.85%(+21.6%) |
| Dec 2024 | -219.59%(-171.9%) | -221.80%(+19.6%) |
| Sep 2024 | - | -275.80%(+38.1%) |
| Jun 2024 | - | -445.45%(+17.8%) |
| Mar 2024 | - | -542.12%(-89.8%) |
| Dec 2023 | 305.48%(+132.4%) | -285.66%(-21.0%) |
| Sep 2023 | - | -236.07%(-148.8%) |
| Jun 2023 | - | -94.89%(+71.8%) |
| Mar 2023 | - | -336.96%(+73.1%) |
| Dec 2022 | -941.39%(-257.9%) | -1253.98%(-82.9%) |
| Sep 2022 | - | -685.59%(+31.3%) |
| Jun 2022 | - | -998.28%(-93.8%) |
| Mar 2022 | - | -515.04%(-13.3%) |
| Dec 2021 | -263.05%(+14.7%) | -454.40%(-4.9%) |
| Sep 2021 | - | -433.08%(-76.5%) |
| Jun 2021 | - | -245.41%(+11.2%) |
| Mar 2021 | - | -276.34%(-27.9%) |
| Dec 2020 | -308.44%(-263.9%) | -216.14%(-35.9%) |
| Sep 2020 | - | -159.05%(-44.5%) |
| Jun 2020 | - | -110.06%(-12.6%) |
| Mar 2020 | - | -97.77%(-4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | -84.75%(+27.4%) | -93.73%(-19.3%) |
| Sep 2019 | - | -78.55%(+19.6%) |
| Jun 2019 | - | -97.73%(+13.5%) |
| Mar 2019 | - | -113.01%(-4.9%) |
| Dec 2018 | -116.66%(-54.8%) | -107.72%(+4.2%) |
| Sep 2018 | - | -112.40%(+0.8%) |
| Jun 2018 | - | -113.36%(-14.6%) |
| Mar 2018 | - | -98.96%(-19.2%) |
| Dec 2017 | -75.35%(-50.2%) | -82.99%(-2.4%) |
| Sep 2017 | - | -81.01%(-9.8%) |
| Jun 2017 | - | -73.75%(-19.1%) |
| Mar 2017 | - | -61.94%(-14.7%) |
| Dec 2016 | -50.15%(+2.6%) | -54.01%(-16.4%) |
| Sep 2016 | - | -46.39%(-18.3%) |
| Jun 2016 | - | -39.23%(-8.9%) |
| Mar 2016 | - | -36.01%(+7.1%) |
| Dec 2015 | -51.50%(+57.3%) | -38.75%(-11.9%) |
| Sep 2015 | - | -34.63%(-8.7%) |
| Jun 2015 | - | -31.85%(+30.7%) |
| Mar 2015 | - | -45.93%(+18.5%) |
| Dec 2014 | -120.72%(-225.6%) | -56.36% |
| Dec 2013 | 96.14% | - |
FAQ
- What is Cidara Therapeutics, Inc. annual return on equity?
- What is the all-time high annual ROE for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual ROE year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly return on equity?
- What is the all-time high quarterly ROE for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly ROE year-on-year change?
What is Cidara Therapeutics, Inc. annual return on equity?
The current annual ROE of CDTX is -219.59%
What is the all-time high annual ROE for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual return on equity is 305.48%
What is Cidara Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, CDTX annual return on equity has changed by -525.07% (-171.88%)
What is Cidara Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of CDTX is -55.62%
What is the all-time high quarterly ROE for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly return on equity is -31.85%
What is Cidara Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, CDTX quarterly return on equity has changed by +389.83% (+87.51%)